Suppr超能文献

[药物对儿茶酚胺释放的抑制作用。冠心病中β-交感神经阻滞的治疗替代方案?]

[Reduction of catecholamine liberation by drugs. Therapeutic alternative to beta sympathicolysis in coronary disease?].

作者信息

Lönne E, Dorn F

出版信息

Fortschr Med. 1981 Oct 15;99(39):1616-20.

PMID:7308929
Abstract

Plasma catecholamines have been determined in 10 persons with healthy coronary circulation (group A) and in 10 patients with coronary cardiac illness (group B) before and immediately after ergometer loading. The loading dosis amounted on average to 177.5 watts for group A and 80 watts for group B. Under load, the catecholamines rose significantly for group A (p less than 0.01) and highly significantly for group B (p less than 0.001). After 10 days of therapy with a combination preparation (12 mg of diphenhydramine hydrochloride, 100 mg of meprobamate, 5 mg of nicotinic acid = Visano-mini), the catecholamines were again determined for groups A and B before and after loading. The catecholamines were not significantly changed by therapy, neither for group A nor B. Under the therapy, the rise in catecholamines caused by load was distinctly lower than before without therapy, namely significantly lowered for group A (p less than 0.01) and slightly significantly for group B (p less than 0.02). Also significantly lowered under therapy in terms of percentage was the catecholamine rise caused by the load, namely by 27% against 75% for group A, by 35% against 89% for group B. As the first results show, Visano-mini seems to constitute an interesting catecholamine inhibiting combination of substances. Whether this might possibly lead to a therapeutic alternative to the betasympathicolysis will have to be determined on the basis of further investigations.

摘要

在10名冠状动脉循环健康者(A组)和10名冠心病患者(B组)进行测力计负荷试验之前及之后立即测定了血浆儿茶酚胺。A组的负荷剂量平均为177.5瓦,B组为80瓦。负荷状态下,A组儿茶酚胺显著升高(p<0.01),B组极显著升高(p<0.001)。在用复方制剂(12毫克盐酸苯海拉明、100毫克甲丙氨酯、5毫克烟酸=维沙诺 - 迷你)治疗10天后,再次测定A组和B组负荷试验前后的儿茶酚胺。治疗后,A组和B组的儿茶酚胺均无显著变化。治疗期间,负荷引起的儿茶酚胺升高明显低于未治疗前,即A组显著降低(p<0.01),B组略有显著降低(p<0.02)。治疗期间,负荷引起的儿茶酚胺升高百分比也显著降低,A组从75%降至27%,B组从89%降至35%。初步结果显示,维沙诺 - 迷你似乎是一种有趣的儿茶酚胺抑制性复方制剂。这是否可能成为β-交感神经阻滞疗法的替代治疗方法,还有待进一步研究确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验